Scienture Holdings, Inc. Common Stock
$0.31
$0.00 (+0.10%)
$0.31Day Range$0.32
Key Statistics
Market Cap
$12.87M
Shares Outstanding
41.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 22, 2008
Round Lot
100
Locale
US
Trading Data
Day Open
$0.31
Day High
$0.32
Day Low
$0.31
Volume
297.8K
VWAP
$0.32
Prev Close
$0.31
Transactions
--
Acc. Volume
--
About Scienture Holdings, Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
PHARMACEUTICAL PREPARATIONSSIC 28349 employees20 AUSTIN BLVD., COMMACK, NY, 11725(800) 261 0281IPO Feb 22, 2008US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001382574
- Composite FIGI
- BBG000RNLYM7
- Share Class FIGI
- BBG001STZBS0
- Ticker Root
- SCNX
- SIC Code
- 2834
About Scienture Holdings, Inc. Common Stock (SCNX) Stock
Scienture Holdings, Inc. Common Stock (SCNX) closed the 2026-09-18 session at $0.31, up 0.10% versus the previous close (+0.00). The stock opened at $0.31 and traded between $0.31 and $0.32 during that session. Session trading volume was 298K shares. The volume-weighted average price (VWAP) is $0.32.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Scienture Holdings, Inc. Common Stock has a market capitalization of $12.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SCNX is listed on the XNAS exchange. The company employs approximately 9 people. Scienture Holdings, Inc. Common Stock is headquartered in COMMACK, NY. The recorded listing date is 2008-02-22.
On this page you can find market SCNX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.